202 related articles for article (PubMed ID: 23033539)
1. Primary generalized glucocorticoid resistance and hypersensitivity: the end-organ involvement in the stress response.
Charmandari E
Sci Signal; 2012 Oct; 5(244):pt5. PubMed ID: 23033539
[TBL] [Abstract][Full Text] [Related]
2. Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity.
Charmandari E; Kino T; Chrousos GP
Endocr Dev; 2013; 24():67-85. PubMed ID: 23392096
[TBL] [Abstract][Full Text] [Related]
3. Primary generalized glucocorticoid resistance and hypersensitivity.
Charmandari E
Horm Res Paediatr; 2011; 76(3):145-55. PubMed ID: 21912096
[TBL] [Abstract][Full Text] [Related]
4. Novel causes of generalized glucocorticoid resistance.
Charmandari E; Kino T
Horm Metab Res; 2007 Jun; 39(6):445-50. PubMed ID: 17578762
[TBL] [Abstract][Full Text] [Related]
5. Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder.
Charmandari E; Kino T; Ichijo T; Chrousos GP
J Clin Endocrinol Metab; 2008 May; 93(5):1563-72. PubMed ID: 18319312
[TBL] [Abstract][Full Text] [Related]
6. A novel point mutation of the human glucocorticoid receptor gene causes primary generalized glucocorticoid resistance through impaired interaction with the LXXLL motif of the p160 coactivators: dissociation of the transactivating and transreppressive activities.
Nicolaides NC; Roberts ML; Kino T; Braatvedt G; Hurt DE; Katsantoni E; Sertedaki A; Chrousos GP; Charmandari E
J Clin Endocrinol Metab; 2014 May; 99(5):E902-7. PubMed ID: 24483153
[TBL] [Abstract][Full Text] [Related]
7. Familial/sporadic glucocorticoid resistance: clinical phenotype and molecular mechanisms.
Charmandari E; Kino T; Chrousos GP
Ann N Y Acad Sci; 2004 Jun; 1024():168-81. PubMed ID: 15265781
[TBL] [Abstract][Full Text] [Related]
8. Generalized glucocorticoid resistance accompanied with an adrenocortical adenoma and caused by a novel point mutation of human glucocorticoid receptor gene.
Zhu HJ; Dai YF; Wang O; Li M; Lu L; Zhao WG; Xing XP; Pan H; Li NS; Gong FY
Chin Med J (Engl); 2011 Feb; 124(4):551-5. PubMed ID: 21362280
[TBL] [Abstract][Full Text] [Related]
9. Glucocorticoid resistance syndrome: A diagnostic and therapeutic approach.
van Rossum EF; Lamberts SW
Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):611-26. PubMed ID: 17161335
[TBL] [Abstract][Full Text] [Related]
10. A novel point mutation in the ligand-binding domain (LBD) of the human glucocorticoid receptor (hGR) causing generalized glucocorticoid resistance: the importance of the C terminus of hGR LBD in conferring transactivational activity.
Charmandari E; Raji A; Kino T; Ichijo T; Tiulpakov A; Zachman K; Chrousos GP
J Clin Endocrinol Metab; 2005 Jun; 90(6):3696-705. PubMed ID: 15769988
[TBL] [Abstract][Full Text] [Related]
11. Corticosteroids: Mechanisms of Action in Health and Disease.
Ramamoorthy S; Cidlowski JA
Rheum Dis Clin North Am; 2016 Feb; 42(1):15-31, vii. PubMed ID: 26611548
[TBL] [Abstract][Full Text] [Related]
12. [Corticosteroid sensitivity, dependence and resistance in inflammatory and immunologic diseases. Physiopathologic review].
Franchimont D; Belaiche J; Geenen V
Rev Med Liege; 1998 Jan; 53(1):33-7. PubMed ID: 9555181
[TBL] [Abstract][Full Text] [Related]
13. Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes.
Charmandari E; Kino T
Eur J Clin Invest; 2010 Oct; 40(10):932-42. PubMed ID: 20649902
[TBL] [Abstract][Full Text] [Related]
14. Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype.
Charmandari E; Kino T; Souvatzoglou E; Vottero A; Bhattacharyya N; Chrousos GP
J Clin Endocrinol Metab; 2004 Apr; 89(4):1939-49. PubMed ID: 15070967
[TBL] [Abstract][Full Text] [Related]
15. A novel mutation of the hGR gene causing Chrousos syndrome.
Nicolaides NC; Geer EB; Vlachakis D; Roberts ML; Psarra AM; Moutsatsou P; Sertedaki A; Kossida S; Charmandari E
Eur J Clin Invest; 2015 Aug; 45(8):782-91. PubMed ID: 26031419
[TBL] [Abstract][Full Text] [Related]
16. A NOVEL GLUCOCORTICOID RECEPTOR MUTATION IN PRIMARY GENERALIZED GLUCOCORTICOID RESISTANCE DISEASE.
Ma L; Tan X; Li J; Long Y; Xiao Z; De J; Ren Y; Tian H; Chen T
Endocr Pract; 2020 Jun; 26(6):651-659. PubMed ID: 32045292
[No Abstract] [Full Text] [Related]
17. Glucocorticoid Resistance.
Nicolaides NC; Charmandari E
Exp Suppl; 2019; 111():85-102. PubMed ID: 31588529
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of Glucocorticoid Signaling.
Vitellius G; Trabado S; Bouligand J; Delemer B; Lombès M
Ann Endocrinol (Paris); 2018 Jun; 79(3):98-106. PubMed ID: 29685454
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid resistance.
Orbak Z
Biochemistry (Mosc); 2006 Oct; 71(10):1073-81. PubMed ID: 17125454
[TBL] [Abstract][Full Text] [Related]
20. Primary Generalized Glucocorticoid Resistance and Hypersensitivity Syndromes: A 2021 Update.
Nicolaides NC; Charmandari E
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
